News
Axinn Advises McKesson on $875M Acquisition of Rx Savings Solutions
September 19, 2022

Axinn is representing McKesson Corporation (NYSE: MCK), a diversified health care services leader, in its $875M acquisition of Rx Savings Solutions, a prescription price transparency and benefit insight company. Announced on September 19, 2022, the acquisition will strengthen McKesson’s ability to help solve the most common medication challenges related to access, affordability and adherence. The Axinn team is led by partners Daniel Bitton and Jeny Maier, and assisted by associate Neelesh Moorthy.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.